Clarity Pharmaceuticals to present at the Congress of the World Federation of Nuclear Medicine and Biology
Sydney, Australia 20 April 2018 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it was invited to give oral presentations and presentations of their posters at the upcoming 12th Congress of the World Federation of Nuclear Medicine and Biology (WFNMB) in Melbourne. Clarity’s CEO, Dr…